These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32143736)

  • 1. Combinative evaluation of primary tumor and lymph nodes to predict pelvic lymphatic metastasis in cervical cancer: an integrated PET-IVIM MRI study.
    Xu C; Li X; Shi Y; Wang B; Sun H
    Cancer Imaging; 2020 Mar; 20(1):21. PubMed ID: 32143736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of integrated PET-IVIM MR in assessing metastases in hypermetabolic pelvic lymph nodes in cervical cancer: a multi-parameter study.
    Xu C; Du S; Zhang S; Wang B; Dong C; Sun H
    Eur Radiol; 2020 May; 30(5):2483-2492. PubMed ID: 32040728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of integrated PET-IVIM MRI in predicting lymphovascular space invasion in cervical cancer without lymphatic metastasis.
    Xu C; Yu Y; Li X; Sun H
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2990-3000. PubMed ID: 33506309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
    Li K; Sun H; Guo Q
    Eur J Radiol; 2019 Apr; 113():153-157. PubMed ID: 30927941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer.
    Gao S; Du S; Lu Z; Xin J; Gao S; Sun H
    Eur Radiol; 2020 Feb; 30(2):1191-1201. PubMed ID: 31493211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between
    Du S; Sun H; Gao S; Xin J; Lu Z; Chen Z; Pan S; Guo Q
    Clin Radiol; 2019 Mar; 74(3):178-186. PubMed ID: 30545566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of [
    Li K; Sun H; Lu Z; Xin J; Zhang L; Guo Y; Guo Q
    Eur J Radiol; 2018 Sep; 106():160-166. PubMed ID: 30150039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Predicting Pelvic Lymph Node Metastasis Based on IVIM-DWI and Texture Parameters of the Primary Lesion and Lymph Nodes in Patients with Cervical Cancer.
    Zhang Y; Zhang KY; Jia HD; Fang X; Lin TT; Wei C; Qian LT; Dong JN
    Acad Radiol; 2022 Jul; 29(7):1048-1057. PubMed ID: 34654623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
    Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
    Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Pretreatment Metabolic PET Parameters in Cervical Cancer Patients With Metabolic Complete Response After Concurrent Chemoradiotherapy.
    Son SH; Jeong SY; Chong GO; Lee YH; Park SH; Lee CH; Hong CM; Jeong JH; Lee SW; Ahn BC; Lee J
    Clin Nucl Med; 2018 Sep; 43(9):e296-e303. PubMed ID: 30036243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography.
    Yoo J; Choi JY; Moon SH; Bae DS; Park SB; Choe YS; Lee KH; Kim BT
    Int J Gynecol Cancer; 2012 Sep; 22(7):1226-33. PubMed ID: 22810970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients.
    Kim SK; Choi HJ; Park SY; Lee HY; Seo SS; Yoo CW; Jung DC; Kang S; Cho KS
    Eur J Cancer; 2009 Aug; 45(12):2103-9. PubMed ID: 19403303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.
    Park SY; Yoon JK; Park KJ; Lee SJ
    Cancer Imaging; 2015 Dec; 15():21. PubMed ID: 26694918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node standardized uptake values at pre-treatment
    Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
    Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
    Shim SH; Kim DY; Lee SJ; Kim SN; Kang SB; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Jan; 144(1):40-45. PubMed ID: 27855989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Prognostic Value of F-18 Pet Metabolic Parameters of Primary Tumors and Regional Lymph Nodes in Patients with Locally Advanced Cervical Cancer Who Are Treated with Concurrent Chemoradiotherapy.
    Chong GO; Jeong SY; Park SH; Lee YH; Lee SW; Hong DG; Kim JC; Lee YS; Cho YL
    PLoS One; 2015; 10(9):e0137743. PubMed ID: 26368542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of magnetic resonance imaging and positron emission tomography/computed tomography in preoperative lymph node detection of uterine cervical cancer.
    Chung HH; Kang KW; Cho JY; Kim JW; Park NH; Song YS; Kim SH; Chung JK; Kang SB
    Am J Obstet Gynecol; 2010 Aug; 203(2):156.e1-5. PubMed ID: 20435285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography.
    Wright JD; Dehdashti F; Herzog TJ; Mutch DG; Huettner PC; Rader JS; Gibb RK; Powell MA; Gao F; Siegel BA; Grigsby PW
    Cancer; 2005 Dec; 104(11):2484-91. PubMed ID: 16270319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of integrated PET-CT in pelvic lymph node staging of cervical cancer before radical hysterectomy.
    Chung HH; Park NH; Kim JW; Song YS; Chung JK; Kang SB
    Gynecol Obstet Invest; 2009; 67(1):61-6. PubMed ID: 18843187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer.
    Crivellaro C; Signorelli M; Guerra L; De Ponti E; Buda A; Dolci C; Pirovano C; Todde S; Fruscio R; Messa C
    Gynecol Oncol; 2012 Oct; 127(1):131-5. PubMed ID: 22772064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.